Search by
Industry
Department

Good Reprint Practices: What the FDA Says Now

Preview this audio conference


The following is a brief excerpt from this audio conference. It is in mp3 format and will play with most media players. Please Contact Us with any questions you may have.


Click the file name to listen to the excerpt ac20080904_sample.mp3


 


Audio conference highlights


After years of arguing about the legality of distributing medical journal articles concerning unapproved uses for approved drugs and devices, the FDA has finally released a draft guidance recognizing such distribution as a normal activity. The guidance on Good Reprint Practices outlines the type of articles suitable for dissemination to healthcare professionals, the types of articles which should not be disseminated, and acceptable methods of distribution. However, in some ways this new guidance may be even more rigorous than past programs. It could even be argued that some of the provisions are unconstitutional.


In this audio conference, our speaker discusses the scope of the draft guidance on Good Reprint Practices and provide expert advice on implementing a program to ensure compliance for drug and device companies.


This audio conference covers:


  • The scope of the FDA draft guidance on Good Reprint Practices
  • The constitutionality of various clauses in the guidance
  • Congressional reaction and what it means
  • Tips on developing a compliance program


About the speaker:


Robert J. Klepinski is an Officer with Fredrikson & Byron and practices in the Food and Drug Administration, Health Care Fraud & Compliance and Intellectual Property service areas. He is also recognized as one of the leading FDA compliance attorneys. He counsels pharmaceutical, medical device, biotech, food and nutritional supplement companies on FDA policy. Previously, he served as a regulatory attorney for Medtronic. While there, he set the legal strategy for FDA compliance, including advertising and promotion, quality systems, regulatory and clinical.


Robert frequently speaks at local and national trade associations on FDA policy. He has been an adjunct professor at the University of Minnesota Law School and a guest lecturer at other law schools, including Northwestern University, Hamline University and William Mitchell College of Law. He is an adjunct professor at St. Thomas University Graduate School of Engineering and its MBA program.


Who should attend?


  • Regulatory Affairs
  • Marketing
  • Business Development
  • Senior Management
  • Legal Affairs


This audio conference is rated General Interest.


*Please note: Each registration covers one line connected to the audio conference. Attendees dialing from separate locations are required to have separate registrations.

Speaker & Time

Robert J. Klepinski, Fredrikson & Byron
Good Reprint Practices: What the FDA Says Now
Title: FDA Compliance Attorney
Duration: 60 minutes
Discount: Buy 2 items, get 25% off your order using coupon code FX25%OFF
Event Type: Previously recorded on 2008-09-04
Item #: ac20080904
4 Sep 2008 
Registration Price:
$249.00

Order Info

Select Order Type:  
Include Transcript With Order?:  
Quantity
More
Less
 
 
Bookmark and Share reviews

Reviews

Average Rating: (based on 3 reviews)

Showing 3 Reviews:

by Regina Xavier
Good Reprint Practices
by Stephanie Moore
Good Reprint Practices: What the FDA Says Now
It was a great conference and made me go talk to my legal team about how they are handling and create some processes surrounding this. It would have been nice if he had added the website and/or link to print the actual Guidance
by Ashley Muma
Marketing Associate
I thought this class was very helpful. The lecturer had extensive knowledge regarding the topic and answered questions effectively. I enjoyed it and found it very information although a little dry at parts.
Rate this item
Similar Events
 
Recently Viewed
© Copyright 2010
ForeignExchange Translations.
All rights reserved.

Home  |   FAQ  |   Blog  |   Translation Services  |   Search  |   Privacy Policy  |   Terms of Use  |   Contact Us